Is AVEO Pharmaceuticals, Inc. (AVEO) a Good Buy in the Healthcare Sector?

Thursday, June 30, 2022 12:59 PM | InvestorsObserver Analysts

Mentioned in this article

Is AVEO Pharmaceuticals, Inc. (AVEO) a Good Buy in the Healthcare Sector?

AVEO Pharmaceuticals, Inc. (AVEO) is near the top in its sector according to InvestorsObserver. AVEO gets an overall rating of 92. That means it scores higher than 92% of stocks. AVEO Pharmaceuticals, Inc. gets a 99 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

AVEO has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on AVEO!

See Full AVEO Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With AVEO Pharmaceuticals, Inc. Stock Today?

AVEO Pharmaceuticals, Inc. (AVEO) stock has gained 9.64% while the S&P 500 is lower by -0.31% as of 12:58 PM on Thursday, Jun 30. AVEO is higher by $0.59 from the previous closing price of $6.12 on volume of 236,839 shares. Over the past year the S&P 500 is down -11.41% while AVEO is higher by 1.82%. AVEO lost -$1.20 per share the over the last 12 months. Click Here to get the full Stock Report for AVEO Pharmaceuticals, Inc. stock.